Jul 29, 2024, 23:26
Luciano Costa provides insight into teclistamab in patients with R/R Multiple Myeloma – VJHemOnc
VJHemOnc shared a post on X:
“A recent subgroup analysis focused on the safety and efficacy of teclistamab in patients with R/R Multiple Myeloma with high-risk features. Luciano Costa of UAB Heersink School of Medicine provides insight into the findings.”
Source: VJHemOnc/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 05:31
Dec 22, 2024, 05:05